The Aspergillus ribonuclease a-sarcin is toxic to intact mammalian cells but the mechanism by which it enters the cells to reach its ribosomal RNA substrate is unclear. Here we have compared the cytotoxicity of a-sarcin to that of ricin, another catalytic toxin that targets the same rRNA sequence but whose mechanism of cell entry is better understood. Intact ricin binds to cell surface components and enters the cells by receptor-mediated endocytosis, whereas the catalytic Ž . polypeptide of ricin the A chain or RTA which, like a-sarcin, is unable to bind to surface components directly and enters cells by fluid phase uptake. Recombinant a-sarcin was produced in Escherichia coli and purified to homogeneity. The protein was soluble, stable and its ability to inhibit in vitro protein synthesis was indistinguishable from that of native a-sarcin. Further, recombinant a-sarcin had the same in vitro protein synthesis inhibition activity as ricin A chain. The cytotoxicity of a-sarcin and ricin A chain to HeLa cells was also the same. The cytotoxicity of a-sarcin was due to its RNAase activity rather than to specific membrane effects at the cell surface, since a mutant containing a single substitution at a putative key catalytic residue had reduced ribonuclease activity and an equivalent reduction in cytotoxicity. One interpretation of the data is that a-sarcin enters mammalian cells in the same way as free ricin A chain. q 1997 Elsevier Science B.V.
Introduction

Ž
. alpha-Sarcin a-sarcin is a member of the Aspergillus ribotoxin family, a group of highly specific ribonucleases that cleave a single phosphodiester bond within a highly conserved loop structure present in Abbreviations: RTA, ricin toxin A chain; RTB, ricin toxin B chain; TKM buffer, 25 mM TrisPHCl, pH 7.6, 25 mM KClP5 mM MgCl2; BMV, brome mosaic virus; DMEM, Dulbecco's Modified Eagle's Medium.
) Corresponding author. Fax: q44 203 523701. E-mail: ml@dna.bio.warwick.ac.uk w x 28S ribosomal RNA 1 . The a-sarcin cleavage site lies between a guanosine and adenosine residue in the sequence AGUACGAGyAGGAAG. This universally-conserved rRNA sequence, sometimes referred w x to as the 'a-sarcin loop' 2 , plays a key functional role during protein synthesis as the site at which w x elongation factors EF-1 and EF-2 bind 3,4 . This important region of rRNA is also the target for other protein toxins, such as the ricin toxin family of w x ribosome-inactivating proteins from plants 5 and the w x Shiga toxin family from bacteria 6 , although these toxins are not ribonucleases but N-glycosidases that remove the adenine residue immediately upstream of w x the G-A bond cleaved by a-sarcin 7,8 .
The Aspergillus ribotoxins, including a-sarcin, w x are toxic to intact mammalian cells 9 . Assuming that this toxicity results from the catalytic action of a-sarcin on rRNA, then this protein must be able to cross a membrane in order to reach its ribosomal substrate in the cytosol. Which membrane is traversed and the mechanism by which this is achieved is unclear at present. a-Sarcin has been reported to effectively inhibit in vivo protein synthesis in several w x tumour cell lines 9,10 and in virally-infected cells w x 11,12 . Studies using model membranes indicate that a-sarcin interacts with acidic phospholipids promotw x ing membrane aggregation and fusion 13,14 . It has been suggested that these observations are significant w x in relation to the cell entry mechanism 15 . However, HeLa cells were relatively insensitive to asarcin but became more sensitive after treatment with phospholipase C which permeabilised the cells to allow entry of the toxin or other macromolecules w x 16 , indicating that the toxin could not readily cross the plasma membrane.
In the present study we have compared the cell entry characteristics of a-sarcin, measured as the ability of externally added toxin to inhibit protein synthesis in intact cells, with those of intact ricin or Ž . free ricin A chain RTA . Ricin enters mammalian cells by endocytosis and kills them by catalyticallymodifying the same 28S rRNA loop targeted by w x a-sarcin 6 . RTA, which in common with a-sarcin w x can interact with model membranes 17,18 , does not directly cross the plasma membrane but rather enters cells by fluid phase uptake before subsequently following the same intracellular transport pathway as w x the endocytosed ricin holotoxin 19 . a-Sarcin and RTA are shown to have very similar in vitro translation inhibition and cytotoxicity profiles, suggesting that the mechanism of cell entry may also be similar for these two protein toxins.
Methods
a-Sarcin expression
a-Sarcin was expressed in E. coli TG2 cells using the secretion vector pIN.ompA2.preAS. This expression vector, kindly supplied by Dr. N. Ulbrich, encodes the OmpA N-terminal signal sequence followed by mature a-sarcin. The a-sarcin insert was w x chemically synthesised as described 20 using the preferred E. coli codons. Transformed E. coli TG2 cells were grown in defined M9 medium at 378C to an OD of 0.5 to 0.6. Expression was induced by 600 the addition of IPTG to a final concentration of 0.5 mM, and the cells were shaken for a further 3 h at 378C. After harvesting, the cells were resuspended in 100 mM Tris P HCl, pH 9.0, 10 mM EDTA, and then disrupted by sonication. Cell debris was removed by centrifugation at 20 000 rpm for 15 min at 48C.
Purification of ra-sarcin
Ammonium sulfate was added to the homogenate to 70% saturation. After centrifugation the pellet, which contained the bulk of the endogenous bacterial proteins, was discarded. The supernatant, by now highly enriched for ra-sarcin, was loaded onto a 1.6 = 40 cm CM-Sepharose column. The remaining E. coli proteins, which did not bind to the column, were removed by washing with 100 mM Tris P HCl, pH 9.0, 10 mM EDTA, before ra-sarcin was eluted as a single protein peak using a linear gradient of Ž . NaCl 0 to 750 mM in the same buffer. Native a-sarcin isolated from Aspergillus giganteus was kindly provided by Dr. N. Ulbrich. The concentration of purified a-sarcin wdetermined from the A value; 280 a calibration curve prepared for native a-sarcin giving a molar extinction coefficient at 280 nm of 2.46 P 10 4 .
Assaying ra-sarcin for biological actiÕity
Specific rRNA cleaÕage
Various concentrations of ra-sarcin were incubated for 30 min at 308C with 30 mg of rabbit Ž reticulocyte ribosomes non-nuclease treated, from . Promega in 20 ml of 25 mM Tris P HCl, pH 7.6, 25 Ž . mM KCl and 5 mM MgCl TKM buffer . Riboso-2 mal RNA was extracted and fractionated by formamide agarose gel electrophoresis as described prew x viously 21 .
Protein synthesis inhibition
Ž Various concentrations of ra-sarcin or RTA where . appropriate were added to in vitro assays in which ( )Ž . brome mosaic virus BMV mRNA was translated in Ž . nuclease-treated rabbit reticulocyte lysates Promega containing unlabelled amino acids with the exception w 35 x w x of S methionine 21 . Total radiolabelled protein synthesised was expressed as a percentage of the amount synthesised in control translations without added toxin.
Cytotoxicity assays
HeLa cells were plated in 96 well flat bottom tissue culture plates at a density of 1.5 P 10 4 cellsrwell in 100 ml of Dulbecco's modified Eagle's Ž . medium DMEM containing 5% foetal calf serum, 2 mM glutamine, 50 Urml penicillin and 50 Urml streptomycin. After overnight incubation at 378C in a CO incubator, the DMEM was shaken off the cells 2 and various concentrations of ra-sarcin or other toxin in 100 ml of fresh DMEM were added to the cells Ž . and incubated at 378C overnight 16 h . The cells were washed in PBS, and protein synthesis was w 35 x measured by the addition of 1 mCi of S methionine in 50 ml of PBS and incubation at 378C for 2 h. Radiolabelled proteins were precipitated by three washes with 5% trichloroacetic acid and, after three further washes with PBS, were released with 50 ml of 0.5 M NaOH and the incorporated radioactivity was determined by scintillation counting.
Preparation of ribosomes
1 ml of non-nuclease treated rabbit reticulocyte lysate was layered over 1 ml of 1 M RNase-free sucrose solution in TKM buffer contained in a polycarbonate ultracentrifuge tube. After centrifugation at 100 000 = g for 40 min at 48C in a Beckman TL-100 centrifuge, the lysate and sucrose solution was carefully removed. The ribosome pellet was washed three times by resuspension in 1 ml of TKM buffer followed by recentrifugation before final resuspension in 300 ml of TKM buffer. Ribosome concentration was determined by measuring the OD of the sus-260 pension.
Mutagenesis
ra-Sarcin DNA in M was mutagenised using the 13 Ž T7-GENe in vitro mutagenesis kit United States . Biochemicals according to the manufacturers instructions. Mutagenesis was confirmed by DNA sequencing using the dideoxy chain termination method.
Other toxins
Native ricin was purchased from Inland Laborato-Ž . ries Austin, TX, USA and recombinant RTA, expressed in and purified from E. coli, was kindly Ž donated by Zeneca Pharmaceuticals Alderley Park, . Cheshire, UK .
Ž . Fig. 1 . Purification of ra-sarcin. a The 70% ammonium sulfate supernatant from homogenates of E. coli expressing a-sarcin was dialysed against 100 mM Tris.HCl, pH 9.0, 10 mM EDTA, and then loaded onto a CM-Sepharose column. After washing to remove unbound protein, ra-sarcin was eluted by a linear NaCl Ž . gradient 0 to 750 mM in the above buffer. Aliquots from selected fractions were analysed by SDS-PAGE and protein bands were visualised by silver staining. Lane 1, molecular weight markers; lanes 2 to 6, wash fractions that did not bind to the column; lanes 7 to 11, fractions across the protein peak eluted Ž . Ž . with NaCl; lane 12, native a-sarcin. b as a , but the gel was blotted onto nitrocellulose and a-sarcin was visualised using rabbit anti-a-sarcin serum. 
Other methods
DNA manipulations, SDS-polyacrylamide gel electrophoresis and Western blotting were carried out by standard published procedures. Antibodies against native a-sarcin were raised in rabbits.
Results
a-Sarcin production
Ž
. Recombinant a-sarcin ra-sarcin produced in Escherichia coli was used throughout this study. We used an expression vector in which the chemically synthesised a-sarcin gene was preceeded by an in frame sequence encoding the N-terminal signal peptide of the OmpA2 protein, a major outer membrane Ž protein of E. coli pIN.ompA2.preAS, which has w x. been described earlier 20 . When this expression vector was used initially, only very low levels of w x a-sarcin production were seen 20 . Under the experimental conditions used in the present work, IPTG-induced expression in E. coli TG2 cells resulted in a high level of a-sarcin production, and SDS-PAGE of the total proteins present in homogenates from such cells revealed the presence of a prominent band of M ; 17 kDa that was not present amongst the pror Ž teins from cells transformed with vector alone data . not shown . The homogenate was brought to 70% Fig. 3 . RNase activity of ra-sarcin. Various concentrations of native or ra-sarcin were incubated with rabbit reticulocyte ribosomes. The rRNA was then extracted and 3 mg of RNA was resolved by agarose gel electrophoresis and visualised by staining with ethidium bromide. The fragment diagnostic of specific RNA cleavage in the a-sarcin loop is indicated by the arrow. Lane 1, untreated ribosomes; lanes 2 to 4, ribosomes treated with 1 ngrml, 100 pgrml or 10 pgrml respectively of native a-sarcin; lanes 5 to 7, ribosomes treated with 1 ngrml, 100 pgrml or 10 pgrml of ra-sarcin. saturation with ammonium sulfate which precipitated the bulk of the endogenous E. coli proteins but not the 17 kDa product. The 17 kDa product was purified to homogeneity in a single step by passing the dialysed supernatant through a 1.6 = 40 cm column containing a CM Sepharose matrix. The endogenous E. Ž coli proteins did not bind to the column Fig. 1a, . lanes 2 to 6 , and the bound 17 kDa protein was eluted using a salt gradient as a single peak around Ž . 0.15 M NaCl Fig. 1a, lanes 7 to 11 . This protein was identified as a-sarcin, having an identical electrophoretic mobility to that of purified native a-sarcin and reacting specifically with rabbit antibodies raised Ž . against native a-sarcin Fig. 1b . A typical yield of purified ra-sarcin produced by this method was 5 mgrl of bacterial culture.
Characterisation of ra-sarcin
Native a-sarcin contains two intramolecular disulfide bonds, linking cysteines residues at position 6 w x and 148, and 76 and 132 respectively 22 . R a-sarcin, directed to the E. coli periplasmic space during its synthesis, also contained two disulfide bonds. On non-reducing SDS-PAGE gels, the disulfide crosslinked a-sarcin displayed a higher electrophoretic mobility than the dithiothreitol-reduced form, a fraction with intermediate mobility confirming the pres-Ž . ence of two disulfide bonds Fig. 2 . R a-sarcin was soluble, being recovered quantitatively in the supernatant when solutions were centrifuged at 100 000 = g Ž for 1 h, and it remained soluble on storage data not . shown .
R a-sarcin was catalytically active. This ribonuclease cleaves 28S rRNA at a specific site close to the 3 X end of the molecule to generate a small RNA fragment of ; 390 ribonucleotides. The presence of this fragment on denaturing formamide gels of total RNA extracted from a-sarcin-treated ribosomes is diagnostic of catalytic activity. As shown in Fig. 3 , ra-sarcin was biologically active, and a comparison of the relative activities of different amounts of ra- ( )sarcin with equivalent amounts of native a-sarcin Ž . indicated that their activities were identical Fig. 3 . This was confirmed by the demonstration that native and ra-sarcin were indistinguishable in their ability to inhibit in vitro protein synthesis in nuclease-treated rabbit reticulocyte lysates programmed with brome Ž . Ž mosaic virus mRNA Fig. 4 , with IC the concen-50 tration of toxin required to give a 50% reduction in .
y10
protein synthesis values of around 10 M. The in vitro protein synthesis inhibition activity of a-sarcin Ž . was essentially the same as that of RTA Fig. 4 . 
The cytotoxicity of ra-sarcin
The cytotoxicity of ra-sarcin to cultured mammalian cells was determined by incubating HeLa cells with various concentrations of toxin for 16 h and susequently determining their ability to incorpow 35 x rate S methionine into cellular protein, expressed as a percentage of the incorporation by control cells not treated with toxin. The concentration of ra-sarcin causing a 50% inhibition of protein synthesis was 5 P 10 y6 M, exactly the same IC value as that 50 Ž . determined for free RTA Fig. 5 . However, both ra-sarcin and RTA were 6 orders of magnitude less cytotoxic than intact ricin, which had an IC value 50 y12 Ž . of 5 P 10 M Fig. 5 . Fig. 6 . The RNasae activity of wild-type and mutant ra-sarcin. Various concentrations of ra-sarcin or ra-sarcinE96A were incubated with rabbit reticulocyte ribosomes, and rRNA was separated and visualised as described in the legend to Ž . wild-type ra-sarcin v and ra-sarcinE96A`.
Cytotoxicty of mutant ra-sarcin with reduced RNAase actiÕity
The Aspergillus ribotoxins share primary sew x quence homology with the RNAases U2 23,24 and ( )w x T1 25 , and key residues present in the active site are conserved. In the case of a-sarcin, the catalytic residues are His50, Glu96, Arg121 and His137. We constructed a point mutant in which Glu96 had been Ž . converted to Ala ra-sarcinE96A . The mutant was expressed in E. coli to the same level as wild-type protein, and was purified to homogeneity by the same procedure. Although the purified mutant retained some RNAase activity, it was significantly less active Ž . than wild-type ra-sarcin Fig. 6 . When ra-sarcin and ra-sarcinE96A were compared in terms of their ability to inhibit in vitro protein synthesis, ra-sarcinE96A was about 80-fold less active under the assay condi-Ž . tions used Fig. 7a . The cytotoxicity of rasarcinE96A to HeLa cells was also approximately Ž . 80-fold less than that of ra-sarcin Fig. 7b . 
Discussion
It has been recognised for some time that a-sarcin is cytotoxic to mammalian cells by causing the inhiw x bition of cellular protein synthesis 10 . Since a-sarcin acts by specific cleavage of 28S rRNA, and since the ribosomes are in the cytosol, catalytically active asarcin must enter this cellular compartment. a-Sarcin w x interacts with phospholipid vesicles 13,14 , and it has been suggested that this interaction may permit the protein to directly cross the plasma membrane to w x gain access to its substrate 9 . RTA is also cytotoxic to mammalian cells, and it catalytically modifies the same 28S rRNA region targeted by a-sarcin. Like a-sarcin, RTA can also interact with phospholipid vesicles, but it does not enter cells by direct traversal w x of the plasma membrane 26 . In the ricin holotoxin, RTA is covalently linked via a single disulfide bond, Ž . w x to a second polypeptide the B chain or RTB 5 . RTB is a galactose-and N-acetylgalactosaminespecific lectin which is responsible for ricin binding to mammalian cells through its interaction with cell surface galactosides. Some of the bound toxin is taken into the cells by endocytosis and, after vesicular transport, RTA crosses an intracellular membrane in order to reach its substrate. Surface binding is essential for potent cytotoxicity, since preventing binding by adding free sugar or by abrogating the RTB galactose binding sites dramatically reduces w x ricin toxicity 27-29 . Free RTA is still cytotoxic, however, since at high enough extracellular concentration a proportion can enter the cell dissolved in the w x fluid taken up by the normal endocytic activity 26 .
Here we have shown that ra-sarcin produced in E. coli, indistinguishable in all aspects from native asarcin, is cytotoxic to HeLa cells with an IC of 50 5 P 10 y6 M. This IC value is in close agreement 50 with values reported earlier for a-sarcin against a w x number of different tumour cell lines 9 . Since asarcin may promote permeability changes in phosw x pholipid vesicles 14 , its toxicity to intact cells could conceivably result from damage to the plasma membrane rather than cleavage of 28S rRNA. This did not seem to be the case, however, since cells incubated with a-sarcin did not leak lactate dehydrogenase suggesting that they had not been permeabilised to w x macromolecules 16 . In the present study we show that a point mutation in an active site residue reduces both the in vitro protein synthesis inhibition ability and the cytotoxicity of ra-sarcin to a similar extent, a correlation that strongly suggests that cytotoxicity is a consequence of RNAase activity rather than a generalised loss of cytosol resulting from damage to the plasma membrane.
The ability of a-sarcin to inhibit in vitro protein synthesis is essentially the same as that of free RTA. Both toxins have equivalent toxic potency to HeLa cells, but both are 10 6 -fold less potent than intact ricin. One possible explanation for a-sarcin and RTA having the same cytotoxicity is that they have the same ability to reach their ribosomal substrate because they enter cells by the same mechanism. RTA is apparently unable to bind directly to surface components and to use such components for receptorw x mediated endocytosis 19 . When the ability to bind to the cell surface is restored to RTA by coupling it to antibodies raised against cell surface antigens or to a natural ligand for cell surface receptors, the RTAcontaining conjugates can have the same cytotoxicity w x as intact ricin 30 . This suggests that in ricin the crucial role of RTB in toxicity is cell surface binding, and that it does not have a necessary role in RTA translocation across a membrane. Free RTA is cytotoxic at high concentration, however, and its cytotoxic potency is equal to that of a-sarcin. We have recently shown that free RTA follows the same intracellular transport route as intact ricin indicating that there is a single intracellular site from which RTA ( )translocates into the cytosol, regardless of the mechaw x nism or the efficiency of cell entry 19 . Since asarcin, in common with RTA, seems to be incapable of directly traversing the plasma membrane, it may reach the cytosol by the same route as ricin and RTA. Alternatively a-sarcin might enter mammalian cells using a different mechanism to RTA, possibly differing in the initial endocytic entry step or in intracellular trafficking and the site of toxin translocation into the cell cytosol. If this is the case, then the relative efficiencies of the two routes are clearly very similarsince a-sarcin and RTA exhibit equivalent cytotoxic potencies.
